Parallax Volatility Advisers, L.P. Adverum Biotechnologies, Inc. Transaction History

Parallax Volatility Advisers, L.P.

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2020 Aug 14, 2020	SELL	$8.53 - $25.64 $516,022 - $1.55 Million	-60,495 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$7.98 - $16.32 $482,750 - $987,278	60,495 New	60,495 $591,000

524K

Ticker ADVM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 99,333,600
Market Cap $720M
Description
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration an...

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.